Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adverse events on the rise

This article was originally published in The Gray Sheet

Executive Summary

Medical device adverse event reports continue to increase, FDA says. In FY 2006, they rose to 210,706, surpassing the 176,351 reported in 2005. Susan Gardner, director of CDRH's Office of Surveillance & Biometrics, suggests that the increase could be due to the device industry's growth. During a Nov. 1 Regulatory Affairs Professionals Society webcast, Gardner noted that "the ratio or percent of deaths, malfunctions and injuries - in spite of increasing reports - remains about the same," adding that the "number of injuries is increasing somewhat in proportion to malfunctions." For 2006, there were 2,735 deaths, 119,070 injuries, 82,493 malfunctions, and 6,408 adverse events classified as "other." Stats for 2005 were 2,347 deaths, 100,158 injuries, 67,183 malfunctions, and 6,663 events classified as other...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel